Articles

Results 11 to 15 of 20
Most popular |Most recent


EU Commission proposes softening of SPC law to assist EU-based manufacturers

Canada, European Union - May 30 2018 The European Commission has proposed a "targeted adjustment" to intellectual property law with a view to reducing the restrictions on EU-based…

Ailsa Carter.

Actavis v Eli Lilly

Canada, European Union, United Kingdom - November 27 2017 Following the Supreme Court's decision in Actavis v Lilly, is there a gap between the interpretation of a patent claim for validity purposes and its…

Ailsa Carter, Gordon Harris.

Ground-breaking declaratory relief from English High Court clears the route to market for Humira biosimilar

United Kingdom - March 6 2017 In a landmark judgment, the High Court has granted a novel type of declaratory relief to clear the route to market for a product facing a raft of…

Jenny Davies.

Eli Lilly's erectile dysfunction patent stands up to scrutiny

United Kingdom - September 1 2016 The English High Court (Patents Court) has ruled in a patent dispute concerned with the treatment of erectile dysfunction. Actavis and Mylan had…

Christopher Freeth.

Subject-matter, scope and second medical use - defining double-patenting

European Union - May 21 2014 On 12 July 1999, The Board of Regents of the University of Texas System (UTS) made an application (application number 99940802.4) for a patent…